Cellectar Biosciences, Inc.
CLRB· Nasdaq
Cellectar Biosciences, Inc.
- Last sale
- Oct 2, 2026 · -2.69%
- Market cap
- $17.11M
- 9.45M shares
- Filings
- 1,021
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $11,498,761 | reported | |
| FY 2024 | 2024-12-31 | $26,136,246 | reported | |
| FY 2023 | 2023-12-31 | $27,266,276 revised | reported | |
| FY 2022 | 2022-12-31 | $18,265,711 revised | reported | |
| FY 2021 | 2021-12-31 | $17,586,469 | reported | |
| FY 2020 | 2020-12-31 | $10,140,681 | reported | |
| FY 2019 | 2019-12-31 | $8,996,058 | reported | |
| FY 2018 | 2018-12-31 | $6,835,229 | reported | |
| FY 2017 | 2017-12-31 | $9,465,666 | reported | |
| FY 2016 | 2016-12-31 | $4,750,414 | reported | |
| FY 2015 | 2015-12-31 | $5,158,874 | reported | |
| FY 2014 | 2014-12-31 | $5,964,453 | reported |
Cellectar Biosciences, Inc. · CIK 1279704 · Engraved from SEC EDGAR
